Evidence map›Paper›PMID 21683389›Full record

ArticleThe Journal of urology2011

Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States.

Sandra H Berry, Marc N Elliott, Marika Suttorp, Laura M Bogart, Michael A Stoto, Paul Eggers, Leroy Nyberg, J Quentin Clemens

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in The Journal of urology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04401176 (A Randomized Trial of Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome), which is not on this map. Cited by 303 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
303citing papers in PubMed, 7 pooled it
23.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04401176 phase2completednot on this mapstarted 2020, after this paper: background citation

A Randomized Trial of Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome

TypeinterventionalSponsorWalter Reed National Military Medical CenterRan2020 to 2023Enrolled58ConditionsInterstitial Cystitis, Bladder Pain SyndromeArmsHeparin & Alkalinized Lidocaine Bladder Instillation, Onabotulinum Toxin A
3 · Its place in the literature

Who cites it

303 citing papers in PubMed, 7 syntheses or guidelines pooled it, 579 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Review
  11. Article
  12. Bladder mucosal afferents detect UTI and aid pathogen clearance.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

243 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Sandra H BerryRAND Corporation, Santa Monica, California.90407-2138, USA. berry@rand.org
Marc N Elliott
Marika Suttorp
Laura M Bogart
Michael A Stoto
Paul Eggers
Leroy Nyberg
J Quentin Clemens
RAND Corporation · USNational Institute of Diabetes and Digestive and Kidney Diseases · USBoston Children's Museum · USGeorgetown University · USUniversity of Michigan–Ann Arbor · US

Funding

Epidemiology of Interstitial Cystitis/Painful Bladder SyndromeU01DK070234 · NIDDK · RAND CORPORATION · PI BERRY, SANDRA H. · 2004 to 2008
$5.5M
NIDDK NIH HHS U01 DK070234NIDDK NIH HHS U01DK070234-01
6 · The paper itself

Abstract

purposeBladder pain syndrome/interstitial cystitis is a poorly understood condition that can cause serious disability. We provide the first population based symptom prevalence estimate to our knowledge among United States adult females. MATERIALS AND

methodsWe developed and validated 2 case definitions to identify bladder pain syndrome/interstitial cystitis symptoms. Beginning in August 2007 we telephoned United States households, seeking adult women with bladder symptoms or a bladder pain syndrome/interstitial cystitis diagnosis. Second stage screening identified those subjects who met case definition criteria. Each completed a 60-minute interview on the severity and impact of bladder symptoms, health care seeking and demographics. Data collection ended in April 2009. Using population and nonresponse weights we calculated prevalence estimates based on definitions spanning a range of sensitivity and specificity. We used United States Census counts to estimate the number of affected women in 2006. The random sample included 146,231 households, of which 131,691 included an adult female. Of these households 32,474 reported an adult female with bladder symptoms or diagnosis, of which 12,752 completed the questionnaire.

resultsBased on the high sensitivity definition 6.53% (95% CI 6.28, 6.79) of women met symptom criteria. Based on the high specificity definition 2.70% (95% CI 2.53, 2.86) of women met the criteria. These percentages translated into 3.3 to 7.9 million United States women 18 years old or older with bladder pain syndrome/interstitial cystitis symptoms. Symptom severity and impact were comparable to those of adult women with established diagnoses. However, only 9.7% of the women reported being assigned a bladder pain syndrome/interstitial cystitis diagnosis.

conclusionsBladder pain syndrome/interstitial cystitis symptoms are widespread among United States women and associated with considerable disability. These results suggest bladder pain syndrome/interstitial cystitis may be underdiagnosed.

Indexed as

AdolescentAdultAgedCystitis, InterstitialFemaleHumansMiddle AgedPrevalenceUnited StatesYoung Adult

Identifiers

PMID21683389
PMCPMC3513327
OpenAlexW2008616142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.